Patience will likely be a virtue for those willing to wait on the Canadian marijuana companies on our list
SmallCapPower | June 13, 2017: Marijuana production is a growing industry, which can yield large capital gains for investors. Investors who have an appetite for risk should check out the five Canadian marijuana companies on our list. They all have triple-digit revenue growth potential, and could yield large gains if they live up to expectations.
Related: For Our Complete Coverage Of Canadian Marijuana Stocks Click Here
Canopy Growth Corp. (TSX: WEED) – $7.84
Pharmaceuticals
Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a diversified cannabis company. The Company, through its subsidiaries Tweed Inc. (Tweed), Bedrocan Canada Inc. (Bedrocan) and Tweed Farms Inc. (Tweed Farms), is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed’s commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed’s built-out production capacity is over 10 climate controlled indoor growing rooms.
- Market Cap: $1,295,338,935
- Total Revenue (LTM): $12,699,000
- Debt to Equity: 3.2%
- 2017 Revenue Growth Expectation: 200%
Aphria Inc. (TSX: APH) – $5.22
Pharmaceuticals
Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company’s retail sales are sold primarily through the Company’s online store, as well as telephone orders. Its wholesale shipments are sold to other Medical Purposes Regulations (MMPR) Licensed Producers. It offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil.
- Market Cap: $722,793,062
- Total Revenue (LTM): $8,433,930
- Debt to Equity: 0.0%
- 2017 Revenue Growth Expectation: 131%
OrganiGram Holdings Inc. (
TSXV: OGI) – $2.31
Pharmaceuticals
OrganiGram Holdings Inc., formerly Inform Exploration Corp., is a Canada-based company, which operates through its subsidiary Organigram Inc. Organigram Inc. is a licensed medical marijuana producer as regulated by Health Canada under the Marihuana Medical Access Regulations (MMAR) of the Government of Canada.
- Market Cap: $237,981,205
- Total Revenue (LTM): $6,127,630
- Debt to Equity: 16.9%
- 2017 Revenue Growth Expectation: 282%
Aurora Cannabis Inc. (
TSXV: ACB) – $2.33
Pharmaceuticals
Aurora Cannabis Inc, formerly Prescient Mining Corp, is a Canada-based company, which is in the business of producing and distributing medical marijuana pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company’s primary business consists of the sale of dried medical cannabis. The Company’s principal market is patients who use medical cannabis in Canada. It operates under the following segments: the production and sale of medical cannabis, as well as patient counseling and outreach services. The Company sells dried medical cannabis by direct delivery to patients through physical delivery services, as well as ordering services through the phone and the Company’s online shop and mobile application.
- Market Cap: $760,096,920
- Total Revenue (LTM): $1,439,270
- Debt to Equity: 175.9%
- 2017 Revenue Growth Expectation: 171%
Cronos Group Inc. (TSXV: MJN) – $1.77
Pharmaceuticals
Canabo Medical Inc, formerly Four River Ventures Ltd, is a Canada-based company, which is engaged in the provision of medical services and non-cannabinoid products for patients suffering from chronic pain and disabling illnesses through health clinics. The Company operates approximately 10 medical clinics across Canada. Its medical clinics are operated by qualified health care practitioners, independent medical marijuana evaluations for employers and insurers, and medical marijuana scientific research. The Company’s subsidiary is Canabo Medical Corporation (CMC). Its CMClinics are located in Toronto, Barrie, Ottawa, Halifax, St. John’s, Calgary, Edmonton, Stoney Creek, Hamilton and Burlington. Each clinic provides cannabinoid educators, who consult with patients to determine the proper treatment for their ailments using medical marijuana based on the medical documentation as prepared by the physician.
- Market Cap: $236,102,197.44
- Total Revenue (LTM): $554,200.00
- Debt to Equity: 11.9%
- 2017 Revenue Growth Expectation: 543%
Disclosure: Neither any of the principals at Small Cap Power, nor their family members, own shares in any of the companies mentioned above.
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. To read more of this Disclaimer please click on the button below:
